DarioHealth Corp
DRIO
NASDAQ
Health Care
$6.70
USD
-$0.11 (-1.54%)
Last close
Market Cap:
$51.41M
Volume:
2.4K
Key Statistics
Previous Close
$6.80
Day Range
$6.43 - $7.30
52 Week Range
$5.84 - $17.74
Average Volume (10 Days)
10K
P/E Ratio
0.00
Dividend Yield
0.00%
About This Company
DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company is headquartered in New York City, New York and currently employs 160 full-time employees. The company went IPO on 2013-03-08. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
CEO
Mr. Erez Raphael
Headquaters
New York City, NEW YORK, US
Founded
2013
Employees
160